Wells Fargo
PCRX icon

Wells Fargo’s Pacira BioSciences PCRX Stock Holding History

Wells Fargo’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-42,300
Closed -$136K – 6514
2017
Q4 		$136K Buy
+42,300
New +$1.68M ﹤0.01% 5170

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo's PCRX Position: Q2 2026 in Review

Wells Fargo increased its Pacira BioSciences (PCRX) stake by 106% in Q2 2026, buying an estimated $456K and bringing the position to 37,481 shares worth $951K. The position accounts for ﹤0.01% of the portfolio, ranked #4144.

Wells Fargo first reported a position in PCRX in Q2 2013 and has held it in 53 quarters since. The position peaked at $110M in Q1 2021. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Wells Fargo held 37,481 shares of Pacira BioSciences worth $951K as of Q2 2026.
  • Wells Fargo bought 19,291 Pacira BioSciences shares in Q2 2026, an estimated $456K.
  • Pacira BioSciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4144 holding.
  • Wells Fargo first reported a position in Pacira BioSciences in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's Pacira BioSciences position peaked at $110M in Q1 2021.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.